Growth Metrics

10x Genomics (TXG) Debt to Equity (2018 - 2019)

10x Genomics' Debt to Equity history spans 2 years, with the latest figure at $0.07 for Q4 2019.

  • On a quarterly basis, Debt to Equity rose 152.44% to $0.07 in Q4 2019 year-over-year; TTM through Dec 2019 was $0.07, a 152.44% increase, with the full-year FY2019 number at $0.07, up 152.44% from a year prior.
  • Debt to Equity hit $0.07 in Q4 2019 for 10x Genomics, roughly flat from $0.07 in the prior quarter.
  • Over the last five years, Debt to Equity for TXG hit a ceiling of $0.07 in Q4 2019 and a floor of -$0.13 in Q4 2018.